• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽-TLR7/8a 协调的 DNA 疫苗引发针对传染病的增强免疫反应。

Peptide-TLR7/8a-Coordinated DNA Vaccines Elicit Enhanced Immune Responses against Infectious Diseases.

机构信息

Key Laboratory of Medical Molecular Virology of MOE/NHC/CAMS, School of Basic Medical Sciences, Shanghai Institute of Infectious Disease and Biosecurity Fudan University, Shanghai 200032, China.

School of Pharmacy, Shanghai Pudong Hospital & Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, 826 Zhangheng Road, Shanghai 201203, China.

出版信息

ACS Biomater Sci Eng. 2024 Jul 8;10(7):4374-4387. doi: 10.1021/acsbiomaterials.4c00749. Epub 2024 Jun 13.

DOI:10.1021/acsbiomaterials.4c00749
PMID:38869358
Abstract

DNA vaccines represent an innovative approach for the immunization of diverse diseases. However, their clinical trial outcomes are constrained by suboptimal transfection efficiency and immunogenicity. In this work, we present a universal methodology involving the codelivery of Toll-like receptor 7/8 agonists (TLR7/8a) and antigen gene using TLR7/8a-conjugated peptide-coated poly(β-amino ester) (PBAE) nanoparticles (NPs) to augment delivery efficiency and immune response. Peptide-TLR7/8a-coated PBAE NPs exhibit advantageous biophysical attributes, encompassing diminutive particle dimensions, nearly neutral ζ potential, and stability in the physiological environment. This synergistic approach not only ameliorates the stability of plasmid DNA (pDNA) and gene delivery efficacy but also facilitates subsequent antigen production. Furthermore, under optimal formulation conditions, the TLR7/8a-conjugated peptide coated PBAE NPs exhibit a potent capacity to induce robust immune responses. Collectively, this nanoparticulate gene delivery system demonstrates heightened transfection efficacy, stability, biodegradability, immunostimulatory effect, and low toxicity, making it a promising platform for the clinical advancement of DNA vaccines.

摘要

DNA 疫苗代表了一种针对多种疾病免疫接种的创新方法。然而,它们的临床试验结果受到转染效率和免疫原性不理想的限制。在这项工作中,我们提出了一种通用的方法,涉及使用 TLR7/8a 缀合肽包被的聚(β-氨基酯)(PBAE)纳米颗粒(NPs)共递送 Toll 样受体 7/8 激动剂(TLR7/8a)和抗原基因,以提高递送效率和免疫反应。肽-TLR7/8a 包被的 PBAE NPs 具有有利的物理特性,包括微小的颗粒尺寸、接近中性的 ζ 电位和在生理环境中的稳定性。这种协同方法不仅改善了质粒 DNA(pDNA)的稳定性和基因传递效率,还有助于随后的抗原产生。此外,在最佳配方条件下,TLR7/8a 缀合肽包被的 PBAE NPs 具有诱导强大免疫反应的强大能力。总的来说,这种纳米颗粒基因传递系统表现出更高的转染效率、稳定性、生物降解性、免疫刺激性和低毒性,使其成为 DNA 疫苗临床应用的有前途的平台。

相似文献

1
Peptide-TLR7/8a-Coordinated DNA Vaccines Elicit Enhanced Immune Responses against Infectious Diseases.肽-TLR7/8a 协调的 DNA 疫苗引发针对传染病的增强免疫反应。
ACS Biomater Sci Eng. 2024 Jul 8;10(7):4374-4387. doi: 10.1021/acsbiomaterials.4c00749. Epub 2024 Jun 13.
2
Prolonged Codelivery of Hemagglutinin and a TLR7/8 Agonist in a Supramolecular Polymer-Nanoparticle Hydrogel Enhances Potency and Breadth of Influenza Vaccination.超分子聚合物-纳米颗粒水凝胶中持续共递送血凝素和 TLR7/8 激动剂可增强流感疫苗的效力和广谱性。
ACS Biomater Sci Eng. 2021 May 10;7(5):1889-1899. doi: 10.1021/acsbiomaterials.0c01496. Epub 2021 Jan 6.
3
Poly(d,l-lactide-co-glycolide) Nanoparticles as Delivery Platforms for TLR7/8 Agonist-Based Cancer Vaccine.聚(D,L-丙交酯-co-乙交酯)纳米粒作为 TLR7/8 激动剂为基础的癌症疫苗的递送平台。
J Pharmacol Exp Ther. 2019 Sep;370(3):715-724. doi: 10.1124/jpet.118.254953. Epub 2019 Jan 4.
4
TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy.TLR7/8 激动剂负载纳米颗粒增强 NK 细胞介导的基于抗体的癌症免疫疗法。
Mol Pharm. 2020 Jun 1;17(6):2109-2124. doi: 10.1021/acs.molpharmaceut.0c00271. Epub 2020 May 21.
5
TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.Toll样受体9(TLR9)激动剂而非TLR7/8激动剂可作为佐剂减轻呼吸道合胞病毒(RSV)福尔马林灭活疫苗增强型疾病,而在初次RSV感染期间使用任何一种激动剂进行治疗都会增加疾病严重程度。
Vaccine. 2009 May 18;27(23):3045-52. doi: 10.1016/j.vaccine.2009.03.026. Epub 2009 Apr 3.
6
Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy.抗原表位-TLR7/8a 缀合物作为自组装无载体纳米疫苗用于个体化免疫治疗。
Acta Biomater. 2022 Mar 15;141:398-407. doi: 10.1016/j.actbio.2022.01.004. Epub 2022 Jan 8.
7
Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.表面修饰的含聚(β 氨基酸酯)纳米粒用于质粒 DNA 的递送。
J Control Release. 2012 Nov 28;164(1):41-8. doi: 10.1016/j.jconrel.2012.09.020. Epub 2012 Oct 5.
8
Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy.可冻干的多功能 Toll 样受体 7/8 激动剂负载的纳米乳液,用于重塑肿瘤微环境和增强癌症免疫治疗。
ACS Nano. 2019 Nov 26;13(11):12671-12686. doi: 10.1021/acsnano.9b04207. Epub 2019 Oct 11.
9
Nanoparticles Presenting Potent TLR7/8 Agonists Enhance Anti-PD-L1 Immunotherapy in Cancer Treatment.纳米颗粒呈递强效 TLR7/8 激动剂增强癌症治疗中的抗 PD-L1 免疫疗法。
Biomacromolecules. 2020 Sep 14;21(9):3704-3712. doi: 10.1021/acs.biomac.0c00812. Epub 2020 Aug 20.
10
Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.自组装纳米疫苗包含 TLR7/8 激动剂和 STAT3 抑制剂,通过增强肿瘤特异性免疫反应增强肿瘤免疫治疗。
J Immunother Cancer. 2021 Aug;9(8). doi: 10.1136/jitc-2021-003132.